(Q33437467)

26 July 2017

title

Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol (English)

1 reference

26 July 2017

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

16 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

16 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

16 November 2022

3

D. W. Eyles

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755839

16 November 2022

4

H. A. Whiteford

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755839

16 November 2022

author name string

Castagnoli N Jr

6

1 reference

26 July 2017

B. Subramanyam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755839

16 November 2022

S. M. Pond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755839

16 November 2022

H. G. Fouda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755839

16 November 2022

N. Castagnoli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1755839

16 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

26 July 2017

16 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1755839

full work available at URL

16 November 2022

https://api.elsevier.com/content/article/PII:0006291X91912285?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

https://api.elsevier.com/content/article/PII:0006291X91912285?httpAccept=text/plain

16 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Biochemical and Biophysical Research Communications

16 November 2022

published in

1 reference

26 July 2017

volume

181

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

573-578

1 reference

Maintenance therapies in schizophrenia

26 July 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

16 November 2022

Tardive dyskinesia

4

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

16 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.

16 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment

16 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Tardive dyskinesia. A discontinuation study.

16 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Haloperidol-induced plasticity of axon terminals in rat substantia nigra.

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment

16 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

MPTP toxicity: implications for research in Parkinson's disease

16 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

16 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Research diagnostic criteria: rationale and reliability

16 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.

16 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds

16 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite

16 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

Is the sigma opiate receptor a proadifen-sensitive subform of cytochrome P-450?

16 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorpan and σ ligands to guinea pig brain

16 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-291X(91)91228-5

16 November 2022

Identifiers

1 reference

26 July 2017

1 reference